Anesthesiology, Pain, and Intensive Care Department, Universidade Federal de São Paulo, São Paulo, Brazil; Latin America Sepsis Institute, São Paulo, Brazil; Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil.
Latin America Sepsis Institute, São Paulo, Brazil; Brazilian Research in Intensive Care Network (BRICNet), São Paulo, Brazil; Research Institute, Hospital do Coração (HCor), São Paulo, Brazil.
Lancet Infect Dis. 2017 Nov;17(11):1180-1189. doi: 10.1016/S1473-3099(17)30322-5. Epub 2017 Aug 17.
The sepsis burden on acute care services in middle-income countries is a cause for concern. We estimated incidence, prevalence, and mortality of sepsis in adult Brazilian intensive care units (ICUs) and association of ICU organisational factors with outcome.
We did a 1-day point prevalence study with follow-up of patients in ICU with sepsis in a nationally representative pseudo-random sample. We produced a sampling frame initially stratified by geographical region. Each stratum was then stratified by hospitals' main source of income (serving general public vs privately insured individuals) and ICU size (ten or fewer beds vs more than ten beds), finally generating 40 strata. In each stratum we selected a random sample of ICUs so as to enrol the total required beds in 1690 Brazilian adult ICUs. We followed up patients until hospital discharge censored at 60 days, estimated incidence from prevalence and length of stay, and generated national estimates. We assessed mortality prognostic factors using random-effects logistic regression models.
On Feb 27, 2014, 227 (72%) of 317 ICUs that were randomly selected provided data on 2632 patients, of whom 794 had sepsis (30·2 septic patients per 100 ICU beds, 95% CI 28·4-31·9). The ICU sepsis incidence was 36·3 per 1000 patient-days (95% CI 29·8-44·0) and mortality was observed in 439 (55·7%) of 788 patients (95% CI 52·2-59·2). Low availability of resources (odds ratio [OR] 1·67, 95% CI 1·02-2·75, p=0·045) and adequacy of treatment (OR 0·56, 0·37-0·84, p=0·006) were independently associated with mortality. The projected incidence rate is 290 per 100 000 population (95% CI 237·9-351·2) of adult cases of ICU-treated sepsis per year, which yields about 420 000 cases annually, of whom 230 000 die in hospital.
The incidence, prevalence, and mortality of ICU-treated sepsis is high in Brazil. Outcome varies considerably, and is associated with access to adequate resources and treatment. Our results show the burden of sepsis in resource-limited settings, highlighting the need to establish programmes aiming for sepsis prevention, early diagnosis, and adequate treatment.
Fundação de Apoio a Pesquisa do Estado de São Paulo (FAPESP).
中低收入国家急性护理服务中的脓毒症负担令人担忧。我们估计了巴西重症监护病房(ICU)成年患者中脓毒症的发病率、患病率和死亡率,并评估了 ICU 组织因素与预后的关系。
我们进行了一项为期一天的 ICU 脓毒症患者时点患病率研究,并对 ICU 中患有脓毒症的患者进行了随访。我们采用全国代表性的伪随机抽样方法,制作了一个抽样框架,最初按地理位置分层。然后,每个层按医院的主要收入来源(为普通公众服务与为私人保险个体服务)和 ICU 规模(10 张床以下与 10 张床以上)进行分层,最终生成 40 个层。在每个层中,我们选择了 ICU 的随机样本,以便在 1690 家巴西成人 ICU 中招募所需的总床位。我们对患者进行了随访,直到 60 天的住院出院截止,从患病率和住院时间估算发病率,并生成全国估计数。我们使用随机效应逻辑回归模型评估死亡率的预后因素。
2014 年 2 月 27 日,随机选择的 227 家(72%)317 家 ICU 提供了 2632 名患者的数据,其中 794 名患有脓毒症(每 100 张 ICU 床位 30.2 例脓毒症患者,95%CI 28.4-31.9)。ICU 脓毒症的发病率为每 1000 名患者日 36.3 例(95%CI 29.8-44.0),788 名患者中有 439 名(55.7%)死亡(95%CI 52.2-59.2)。资源可用性低(比值比[OR]1.67,95%CI 1.02-2.75,p=0.045)和治疗的充分性(OR 0.56,0.37-0.84,p=0.006)与死亡率独立相关。预计每年 ICU 治疗脓毒症的成人发病率为 290 例/10 万(95%CI 237.9-351.2),每年约有 42 万例,其中 23 万例在医院死亡。
巴西 ICU 治疗的脓毒症的发病率、患病率和死亡率都很高。结果差异很大,与获得充足的资源和治疗有关。我们的结果显示了资源有限环境中的脓毒症负担,突出了需要建立旨在预防脓毒症、早期诊断和充分治疗的方案。
圣保罗州研究支持基金会(FAPESP)。